Verastem (VSTM) Total Current Liabilities (2011 - 2026)

Verastem's (VSTM) quarterly Total Current Liabilities came in at $66.8 million in Q1 2026, up 87.67% year-on-year from $35.6 million in Q1 2025, and down 7.5% quarter-over-quarter from $72.3 million in Q4 2025.

Verastem (VSTM) Total Current Liabilities (2011 - 2026) Analysis & Trends

Verastem's Total Current Liabilities history runs 16 years deep, the most recent figure standing at $66.8 million for Q1 2026.

  • On a quarterly basis, Total Current Liabilities rose 87.67% year-over-year to $66.8 million in Q1 2026; TTM through Mar 2026 was $66.8 million, a 87.67% increase from a year earlier, with the FY2025 full-year figure at $72.3 million, up 133.33% from the prior year.
  • Total Current Liabilities eased to $66.8 million in Q1 2026 per VSTM's latest filing, from $72.3 million in the prior quarter.
  • Across five years, Total Current Liabilities topped out at $72.3 million in Q4 2025 and bottomed at $16.9 million in Q1 2022.
  • The 5-year median for Total Current Liabilities is $26.7 million (2024), against an average of $34.4 million.
  • Across the five-year window, Total Current Liabilities grew 3.46% in 2023 and jumped 133.33% in 2025, its largest moves.
  • Year by year, Total Current Liabilities stood at $21.7 million in 2022, then advanced by 21.77% to $26.4 million in 2023, then increased by 17.41% to $31.0 million in 2024, then surged by 133.33% to $72.3 million in 2025, then decreased by 7.5% to $66.8 million in 2026.
  • Per Business Quant, the three latest VSTM Total Current Liabilities figures stand at $66.8 million (Q1 2026), $72.3 million (Q4 2025), and $59.7 million (Q3 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Current Liabilities (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - 56.01 Mn
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - 66.94 Mn
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn 1.81 Bn
4 NuCana 279.75 Bn 279.75 Bn - 6.38 Mn
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn 3.88 Bn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn 5.11 Bn
7 Belite Bio 62.51 Bn 62.51 Bn - -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn 1.58 Bn
9 Revolution Medicines 37.78 Bn 37.78 Bn - 289.60 Mn
10 Verastem 166.09 Mn -31.73 Mn 15.90 Mn 66.85 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 66.85 Mn
Dec 31, 2025 72.27 Mn
Sep 30, 2025 59.71 Mn
Jun 30, 2025 50.36 Mn
Mar 31, 2025 35.62 Mn
Dec 31, 2024 30.97 Mn
Sep 30, 2024 37.37 Mn
Jun 30, 2024 30.35 Mn
Mar 31, 2024 26.73 Mn
Dec 31, 2023 26.38 Mn
Sep 30, 2023 23.81 Mn
Jun 30, 2023 20.79 Mn
Mar 31, 2023 22.36 Mn
Dec 31, 2022 21.66 Mn
Sep 30, 2022 21.87 Mn
Jun 30, 2022 20.09 Mn
Mar 31, 2022 16.89 Mn
Dec 31, 2021 18.59 Mn
Sep 30, 2021 13.54 Mn
Jun 30, 2021 12.74 Mn